Publication | Closed Access
Recombinant Human Erythropoietin Is Associated with Increased Overall Survival in Patients with Multiple Myeloma
33
Citations
16
References
2006
Year
rhEPO was associated with improved overall survival in this population of anemic multiple myeloma patients with SWOG stages of II, III and IV. A prospective randomized trial is warranted to corroborate this finding.
| Year | Citations | |
|---|---|---|
Page 1
Page 1